INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Designed To Help Sites Increase Clinical Trial Capacity
IQVIA One Home for Sites is a platform that serves as a neutral aggregator, connector, and communicator of the key systems and tasks a clinical research site needs to perform across all the trials it is conducting.
-
Site Engagement Doesn't Start At First Patient In
Site engagement starts long before enrollment. Explore how well-designed investigator meetings can set the tone, build trust, and give site teams the momentum they need to deliver.
-
Patient Centric Clinical Trials: Why Transportation Is A Timeline Risk
Address transportation barriers to reduce protocol deviations and data gaps. Strategies that lower travel burden protect study timelines and improve visit adherence for better trial outcomes.
-
Insights From Facilitating Over A Billion Dollars In Vendor Contracts
By transforming vendor selection from a manual task into a data-driven, strategic process, sponsors can build stronger, more effective clinical trial teams.
-
Clinical Leader Smart Sourcing Solutions Expo: Retention By Design9/9/2025
Enhance participant retention through intuitive UX and real-time site support tools, while seamlessly integrating with IRT, EDC, and third-party platforms.
-
Technology Fragmentation Is One Of The Biggest Hidden Risks In Clinical Trials4/6/2026
Reclaim your research day by reducing manual data entry. Learn how connecting operational and financial workflows eases administrative burdens and supports site sustainability.
-
Clinical Trial Budgeting Faces Pressure To Modernize6/26/2026
Outdated budget data slows trial startup. Real-time market benchmarking helps sites and sponsors negotiate faster and get treatments to patients sooner.
-
Early-Stage Biotech's AI Advantage Is A Window That Closes5/6/2026
The "greenfield" advantage allows biotechs to build AI-native trials from the start, replacing manual data entry with automated workflows and structured human oversight for better data integrity.
-
Using Technology To Reduce Monitoring Costs And Increase Quality2/18/2025
Join industry experts as they discuss how the true value of DDC lies not just in the cost of the technology itself but in the operational efficiencies it unlocks.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Solve mission critical challenges and bring life-changing therapies to patients faster with Advarra Consulting.
-
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
-
Strategic planning, data-driven decisions, and global coordination accelerate clinical timelines while ensuring quality. Explore risk-based monitoring and practical ways to overcome complexity.
-
Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.
-
Antibody-drug conjugates (ADCs) are transforming cancer care by combining precision antibody targeting with potent payloads to improve patient outcomes.